A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.
about
A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor.
description
2016 թվականի օգոստոսի 30-ին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
A phase 1 study of the safety, ...... a selective PDE10A inhibitor.
@en
A phase 1 study of the safety, ...... a selective PDE10A inhibitor.
@nl
type
label
A phase 1 study of the safety, ...... a selective PDE10A inhibitor.
@en
A phase 1 study of the safety, ...... a selective PDE10A inhibitor.
@nl
prefLabel
A phase 1 study of the safety, ...... a selective PDE10A inhibitor.
@en
A phase 1 study of the safety, ...... a selective PDE10A inhibitor.
@nl
P2093
P2860
P1433
P1476
A phase 1 study of the safety, ...... a selective PDE10A inhibitor.
@en
P2093
Hakop Gevorkyan
Jinhui Xie
Lambros Chrones
Thomas A Macek
P2860
P2888
P304
P356
10.1007/S00213-016-4412-9
P577
2016-08-30T00:00:00Z